Viewing Study NCT00668733


Ignite Creation Date: 2025-12-25 @ 2:44 AM
Ignite Modification Date: 2026-05-16 @ 2:53 AM
Study NCT ID: NCT00668733
Status: COMPLETED
Last Update Posted: 2010-07-20
First Post: 2008-04-24
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Follow-up Study to Evaluate Sustained Clearance Rates of Actinic Keratoses up to One Year
Sponsor: Graceway Pharmaceuticals, LLC
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Actinic Keratoses View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Actinic keratoses View
None Dermatologic disease View